Accretion Pharmaceuticals Limited (NSE:ACCPL)
67.30
+3.20 (4.99%)
At close: Jan 22, 2026
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.